HTCO HighTrend posts solid core business segment results even as broader consumer spending headwinds persist Adaptive Bio ADPT Stock Market Risk 232 20260427 Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval